Detalhe da pesquisa
1.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
N Engl J Med
; 385(17): 1547-1558, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670042
2.
Dietary Modulation of the Human Gut Microbiota and Metabolome with Flaxseed Preparations.
Int J Mol Sci
; 23(18)2022 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36142393
3.
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.
Nat Commun
; 15(1): 3962, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730247
4.
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.
Gastroenterology
; 141(3): 890-899.e1-4, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699798
5.
Fermentative Liberation of Ellagic Acid from Walnut Press Cake Ellagitannins.
Foods
; 11(19)2022 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230178
6.
Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy.
Am J Obstet Gynecol
; 204(2): 169.e1-8, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21284968
7.
Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial.
Hum Vaccin
; 5(5): 315-21, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19011374
8.
A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men.
Vaccine
; 34(35): 4205-4212, 2016 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354258
9.
The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children.
Vaccine
; 34(35): 4221-4228, 2016 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27364096
10.
Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.
Hum Vaccin Immunother
; 12(8): 2135-2141, 2016 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002793
11.
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials.
Pediatrics
; 138(2)2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27422279
12.
Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
Vaccine
; 33(20): 2379-86, 2015 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25765966
13.
A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls.
Pediatr Infect Dis J
; 34(9): 992-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26090572
14.
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels.
Cancer Gene Ther
; 9(3): 289-95, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11896446
15.
Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2.
J Biomed Biotechnol
; 2003(3): 194-201, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12975534
16.
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
Vaccine
; 32(31): 3942-9, 2014 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852717
17.
Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial.
Vaccine
; 31(11): 1496-502, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23313654
18.
Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
Vaccine
; 30(20): 3082-9, 2012 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22406278
19.
Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin.
Pediatr Infect Dis J
; 31(11): 1166-72, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22772170
20.
Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine.
Clin Vaccine Immunol
; 18(5): 878-84, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21389149